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Abstract: The main purpose of the present study was to perform the expression in Pichia pastoris X-33 of the human paraoxonase 1
(hPON1) enzyme, which is a mammalian serum protein. Extracellular hPON1 enzyme was expressed with the pPICZαA vector using
a strong AOX promoter, and enzyme secretion in the fermentation medium was achieved by means of Saccharomyces cerevisiae alpha
factor signal sequence. The recombinant cells were grown in a shaking flask containing production medium. SDS-PAGE and Western
blot analysis illustrated that the molecular mass of extracellular hPON1 enzyme produced by the recombinant P. pastoris strain was
59.1 kDa. Biochemical characterization of the enzyme was carried out after purification with a Probond affinity column. The purified
paraoxonase 1 activity was determined as 18.9 U/mL; however, enzyme activity reached 31.27 U/mL at the end of the characterization
studies. According to the results, KM and Vmax values were 0.025 mM and 28.4 U/mL, respectively, in 100 mM glycine-NaOH buffer (pH
10) containing 2 mM Ca2+ at 15 °C. This is the first report on the expression and production of hPON1 in P. pastoris.
Key words: Pichia pastoris X-33, hPON1, recombinant protein, purification, characterization

1. Introduction
Paraoxonase 1 (PON1), whose activity is related to
the toxicology of organophosphorus compounds and
cardiovascular health, is a mammalian serum protein
(Shih et al., 1998; Lusis, 2000; Draganov and La Du, 2004).
The human paraoxonase (PON) gene family is composed
of PON1, PON2, and PON3 members lying together on
chromosome 7. By far, PON1 is the most studied family
member (Draganov and La Du, 2004). Human serum
paraoxonase 1 (hPON1) is a Ca2+-dependent glycoprotein
with a molecular mass of 43‒45 kDa consisting of 354
amino acids and tightly associated with high-density
lipoprotein (HDL) (Sorenson et al., 1999; Lu et al., 2006).
This glycosylated enzyme has three Cys residues, which
contain two that form a disulfide bond (Harel et al.,
2004). The enzyme, synthesized principally in the liver,
is named after paraoxon (an insecticide) and is one of its
most studied substrates. This enzyme can hydrolyze the
active metabolites of nerve agents such as sarin, soman,
and several organophosphorus insecticides such as
chlorpyrifos oxon and diazoxon (Costa and Furlong, 2002;
Costa et al., 2003).
Bacteria and yeasts are used largely for producing
recombinant proteins. In spite of expressing recombinant
* Correspondence: yagmurunver@yahoo.com

proteins, using E. coli is both inexpensive and effective
(Jana and Deb, 2005; Francis and Page, 2010), as the
capability of E. coli is inadequate for many recombinant
proteins to be folded of protein and formed of disulfide
bonds (Brondyk, 2009). Particularly, the expression of
cysteine-rich proteins with their native conformations
are difficult in bacteria (Nilsson et al., 1991; Ostermeier
et al., 1996). This difficulty can be avoided by using the
Pichia pastoris expression system. P. pastoris, known
as a methylotrophic yeast, has become one of the most
convenient yeast systems for producing recombinant
proteins for industrial and research purposes (MacauleyPatrick et al., 2005). Due to being easily manipulated
on a genetic level, it is possible to add posttranslational
modifications, as well as use with many eukaryotic
organisms and a number of strong promoters to perform
heterologous expression. Thus, many scientists choose to
use this exclusive yeast expression system for producing
heterologous proteins (Cereghino and Cregg, 2000;
Macauley-Patrick et al., 2005). Recombinant proteins
can also be secreted into culture media by the P. pastoris
secretory pathway. Consequently, the effectiveness of
disulfide bond formation and protein folding can be
increased and the procedure of the purification can be
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simplified by this expression system (Almeida et al., 2001;
Mengwasser et al., 2011). To date, some investigators have
used E. coli expression systems for recombinant hPON1
production (Stevens et al., 2008; Suzuki et al., 2010).
However, to our best knowledge, there are no studies on
the expression and production of hPON1 in P. pastoris.
This is the first report on the production of hPON1 in a P.
pastoris expression system and we understand that it is a
definitive system for the expression of applicable hPON1
with the extracellular production in its native form.
2. Materials and methods
2.1. Strains, plasmids, and reagents
The yeast shuttle expression vector pPICZαA, E. coli strain
One Shot TOP10, P. pastoris strain X-33, adult human liver
cDNA, Zeocin, High Pure Plasmid Isolation Kit, Anti-His
(C-term)-HRP antibody, and Probond Nickel Chelating
Resin were purchased from Invitrogen (USA). Restriction
enzymes, T4 DNA ligase, and DNA and protein ladder
were obtained from Fermentas (USA). PCR primers were
synthesized by Metabion Company (Germany) and the
GenElute Gel Extraction Kit was purchased from Sigma
(USA).
2.2. Construction of the recombinant vector
The DNA coding sequence of hPON1 from
human liver cDNA (GenBank accession number
NM_000446.5) was amplified. Forward and reverse
primers used in amplifying the target gene by PCR
were GAGAATTCATGGCGAAGCTGA (F) and
GCGTCTAGAGAGCTCACAGTAAAGAG
(R),
respectively. The PCR products containing restriction
sites of EcoRI and XbaI were digested with these enzymes
and inserted into pPICZαA containing α-factor signal
sequence and AOX1 promoter. The resulting construct also
contained a c-Myc tag and a 6xHis-tag at the C-terminus.
PCR conditions were performed with an initial
denaturation at 94 °C for 4 min and 35 cycles of
amplification including denaturation at 94 °C for 1 min,
annealing at 61 °C for 1 min, and extension at 72 °C for 1.5
min. The other extension was then performed at 72 °C for
5 min. The resulting PCR product purified from the gel was
digested with EcoRI and XbaI and ligated into the EcoRIXbaI digested and gel-purified vector pPICZαA to obtain a
recombinant plasmid. Competent E. coli One Shot TOP10
cells combined with this plasmid were grown in Law salt
LB agar (1% tryptone, 0.5% yeast extract, 0.5% NaCl, and
2% agar) at a pH of 7.5, as recommended. Optionally,
25‒50 µg/mL of Zeocin was added. Colony PCR was
performed using gene primers to confirm the positive
clones and restriction enzyme digestion was performed
to affirm whether the gene insertion was correct. DNA
sequencing was performed by İontek Company (Turkey)
after isolating recombinant plasmid from the positive
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transformant. The constructed expression vector was
named as pPICZαA-hPON1.
2.3. P. pastoris transformation and selection of
transformants
Competent Pichia pastoris X-33 cells were prepared by
using LiCl as defined in the Easy Select Pichia Expression
System manual from Invitrogen. The pPICZαA-hPON1
was linearized using restriction endonuclease PmeI and
transformed to the competent cells. Transformants were
selected on YPD plates (2% dextrose, 2% peptone, 1% yeast
extract, and 2% agar) containing 400 µg/mL Zeocin after
incubating 50 µL of competent cells for 1 h and 4 h at 30
°C. The positive yeast clones were confirmed by colony PCR
with forward and reverse primers of the insert gene. PCR
was performed with an initial denaturation at 94 °C for 4
min and 35 cycles of amplification including denaturation
at 94 °C for 1 min, annealing at 61 °C for 1 min, and
extension at 72 °C for 1.5 min. One negative control
transformant and two positive transformants were selected
for the expression of recombinant human PON1 (rhPON1).
The selected transformants were precultured with 50 mL of
BMGY medium (1% (v/v) glycerol, 2% peptone, 1% yeast
extract, 100 mM potassium phosphate, pH 6, 1.34% (w/v)
yeast nitrogen base with ammonium sulfate and without
amino acids and 4 × 10−5% (w/v) biotin) in a 500-mL baffled
flask at 30 °C for 18 h on a 225-rpm shaker. Harvested cells
from culture media were resuspended to an OD600 of 1.0
in BMMY medium (0.5% (v/v) methanol, 2% peptone,
1% yeast extract, 100 mM potassium phosphate, pH 6,
1.34% (w/v) yeast nitrogen base with ammonium sulfate
and without amino acids and 4 × 10−5% (w/v) biotin) for
induction of expression. Methanol adjusted to 0.5% of the
final concentration was added to culture media every 24
h for induction maintenance. The culture was centrifuged
at 3000 rpm and 4 °C for 15 min after 48 and 72 h. The
obtained supernatants were used for SDS-PAGE analysis
and enzyme activity assay. For selection of the best enzyme
producer clone, enzyme activities and SDS-PAGE results of
clones were analyzed and compared with each other.
2.4. Production of recombinant enzyme
The selected best clone was inoculated on BMGY medium
for precultivation. After 18 h of incubation, the culture was
centrifuged and the obtained cells were transferred to 50
mL of BMMY medium. The cells in BMMY medium were
incubated by methanol induction at 30 °C at 24-h intervals
for 120 h on a 280-rpm shaker. The culture supernatants
were used for SDS-PAGE analysis and enzyme activity
assay, and concentrated supernatants using the TCA
protein precipitation method (Bensadoun and Weinstein,
1976) were also analyzed by western blot using an anti-His
(C-term)-HRP antibody. Casamino acid (1%) and sorbitol
(3%) were added to the medium to increase production of
rhPON1 by determining optimum incubation time.
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2.5. Enzyme activity assay
Recombinant paraoxonase activity was detected at 25
°C using paraoxon (diethyl p-nitrophenyl phosphate) (2
mM) as a substrate in 50 mM glycine-NaOH (pH 10.5)
containing 1 mM CaCl2. The enzyme assay was performed
according to estimation of p-nitrophenol at 412 nm.
Calculation of the enzyme activity was done with the
molar extinction coefficient of p-nitrophenol (ε = 18,290
M−1 cm−1 at pH 10.5) (Renault et al., 2006). The enzyme
amount that hydrolyses 1 µmol of the substrate at 25 °C
was described as one enzyme unit. A spectrophotometer
(Beckman Coulter, USA) was used to perform the assays.
2.6. Purification and quantification of rhPON1 protein
Protein purification was carried out for the analysis of the
biological activity of rhPON1. The highest enzyme producer
colony was grown in 50 mL of BMMY medium to induce
expression. The supernatant of the culture was collected
after 96 h of induction and protein was concentrated to
10-fold with an Amicon filter. The filtrate was bound to the
Probond affinity column, which was equalized with native
binding buffer (0.5 M NaCl and 50 mM NaH2PO4, pH 8).
After elimination of the proteins without His tag using
wash buffer (0.5 M NaCl, 20 mM imidazole, and 50 mM
NaH2PO4, pH 8), the recombinant protein elution from
the nickel-chelating resin was performed using elution
buffer (0.5 M NaCl, 250 mM imidazole, and 50 mM
NaH2PO4, pH 8). Dialysis of the elution was performed
twice for protein desalting using sodium phosphate (pH
8). The obtained sample was analyzed by SDS-PAGE and
the Bradford method was used for determination of total
protein concentration using bovine serum albumin as the
standard (Bradford, 1976). All samples were analyzed in
triplicate.
2.7. Purified rhPON1 characterization
The eluted fractions of rhPON1 protein were collected
and the obtained products were analyzed by SDS-PAGE.
The effect of pH on enzyme activity was determined at 25
°C in 50 mM potassium phosphate buffer for pH values
of 5.5‒8.0, Tris-HCl buffer for pH values of 7.5‒9.0, and
glycine-NaOH buffer for pH values of 9.0‒10.5. For
the determination of optimum buffer concentration on
enzyme activity, different concentrations of glycineNaOH buffer (20‒250 mM) were studied and the effect
of temperature (ranging from 4 to 90 °C) on enzyme
activity was determined at optimum pH and optimum
glycine-NaOH buffer concentration. Finally, enzyme
activity assay was performed using at least five different
paraoxon concentrations in optimum conditions for the
determination of KM and Vmax values.

3. Results
3.1. Construction and transformation of pPICZαAhPON1
The hPON1 gene was amplified (S1) and integrated into
the vector (Figure 1). Colony PCR, DNA sequencing,
and restriction digestion of the pPICZαA-hPON1
proved that the hPON1 gene was inserted in the correct
position on pPICZαA (S2, S3, and S4). PmeI-linearized
pPICZαA-hPON1 was transformed into P. pastoris X-33
strains and the cells were spread on YPD plates to screen
transformants. After the incubation, colony PCR was done
with selected colonies (S5).
3.2. Selection of high-expression yeast clone
The results of enzyme activity assay obtained from two
correct yeast transformants by using culture supernatants
showed that the maximum activity obtained by colony
6 was 10.12 U/mL, whereas less activity (7.23 U/mL)
was observed in the supernatant of colony 3 at 72 h.
This result was consistent with the SDS-PAGE analysis,
suggesting that there was no band related to the control,
and no almost visible amount of hPON1 was seen in the
cultivation medium of colony 3 (Figure 2a). On the other
hand, 9.8 g/L and 9.0 g/L cell dry weights were obtained
by colony 3 and colony 6 at 72 h, respectively. Colony 6
was selected for recombinant enzyme production in the
following experiments.

Figure 1. Construction of recombinant plasmid pPICZαAhPON1. The insert gene (hPON1) was cloned into the EcoRI
and XbaI restriction enzyme sites of the pPICZαA vector.
AOX1, alcohol oxidase 1 promoter; AOX1 TT, transcriptional
termination region from AOX1 gene; PTEF1, transcription
elongation factor 1 gene promoter from Saccharomyces cerevisiae;
PEM7, synthetic prokaryotic promoter; Zeocin, resistance gene;
CYC1 TT, transcription termination region from Saccharomyces
cerevisiae CYC1 gene; pUC ori, pUC origin of replication.
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Figure 2. a) SDS-PAGE analysis for selecting the best producer recombinant yeast colony. M: Marker;
1: control (P. pastoris containing empty vector); 2, 3: colony 6; 4, 5: colony 3. b) SDS-PAGE analysis of
recombinant protein in culture media. M: Marker, 1: 24 h, 2: 48 h, 3: 72 h, 4: 96 h, 5: 120 h.

3.3. Production, purification, and quantification of
recombinant enzyme
The selected colony (colony 6) was grown in BMMY
medium containing 1% casamino acid and 3% sorbitol
and induced by 0.5% methanol at 24-h intervals for
120 h. According to the SDS-PAGE analyses of culture
supernatants (Figure 2b) as well as purified enzyme
(Figure 3a), the induced protein had a molecular mass of
59.1 kDa. In the case of the SDS-PAGE analyses, western
blot analysis could also show that the molecular mass of
the produced protein was 59.1 kDa (Figure 3b). As for
enzyme activity analyses, it was determined that although
the highest biomass amount (24.8 g/L) was obtained after
120 h, the enzyme activity reached its highest value (16.49
U/mL) after 96 h (Figure 4a). The purified protein was
10.1 mg/mL and enzyme activity was 18.9 U/mL. Thus,
the specific enzyme activity was calculated as 1.87 EU/mg.

3.4. Enzyme characterization of purified rhPON1
For determining the properties of purified rhPON1,
paraoxon was used as a substrate and the reactions were
performed as described above at 25 °C. The maximum
activity of rhPON1 was at pH 10.0 with glycine-NaOH
buffer (21.5 U/mL). On the other hand, activities were
observed in Tris-HCl buffer at pH 8.5 and 9.0, while no
activity was determined in potassium phosphate buffer
at any of the pH ranges tested (Figure 4b). The optimum
buffer concentration for enzyme activity was determined
as 100 mM (30.29 U/mL) (Figure 4c) when the different
concentrations of glycine-NaOH buffer from 20 to 250
mM were studied. The optimum temperature for the
enzyme was determined as 15 °C (31.27 U/mL) (Figure
4d). Finally, KM and Vmax values were determined to be
0.025 mM and 28.4 U/mL under the optimum conditions,
respectively.

Figure 3. a) SDS-PAGE analysis of purified recombinant protein (silver staining). b) Western blot analysis of
recombinant protein from culture media. M: Marker, 1: 120 h, 2: 96 h, 3: 72 h, 4: 48 h, 5: 24 h.
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Figure 4. Activity assays of recombinant hPON1. a) Effect of incubation time on activity and biomass. b) Effect of pH on activity of
rhPON1. c) Effect of ionic velocity on activity of rhPON1. d) Effect of temperature on activity of rhPON1.

4. Discussion
Recombinant proteins obtained for in vitro and in vivo
activity studies need to correct disulfide bond formation.
Although in bacteria, the expression of proteins containing
disulfide bond generally collapses, the P. pastoris yeast
system can effectively express functional proteins
containing a wide range of disulfide bonds by means
of its secretory pathway (Almeida et al., 2001; Li et al.,
2009). As endogenous proteins belonging to P. pastoris are
secreted at low levels, the expressed recombinant proteins
can be easily obtained from the culture medium (Gurkan
and Ellar, 2005). Similarly, Li et al. (2012) used E. coli for
producing recombinant fish IGF-1 and reported that the
protein mainly expressed within the cytoplasm needed
refolding and additional cell disruption steps to produce
a biologically active peptide. However, the protein was
successfully secreted and purified from the medium when
they studied with same protein in P. pastoris.
In this study, the expression vector containing the
hPON1 sequence was constructed and combined with
the P. pastoris X-33 genome. The 6xHis-tagged rhPON1
protein expressed by the methanol-inducing AOX1
promoter was secreted into the culture medium by means
of the α-factor signal peptide. The recombinant strain
could effectively secrete the hPON1 for 96 h with 0.5%
methanol induction and the protein was indicated by SDS-

PAGE and western blot. The rhPON1 activity analysis was
detected as quantitative. The secreted rhPON1 protein
was purified through a Probond affinity column and some
biochemical characteristics of the purified recombinant
enzyme were also examined.
As seen from Figure 2a, there was no band in the
negative control as well as in colony 3, which could not
produce a visible amount of hPON1. One possible reason
for this result might be the hydrolysis of hPON1 by various
yeast proteases synthesized in the cell. Therefore, we can
conclude that high amounts of proteases might have
caused rapid degradation of hPON1 in colony 3 because of
high cell concentration (9.8 g/L cell dry weight). Moreover,
the extent of induction time influences proteolysis;
increasing the residence time for the hydrolysis of hPON1
enzyme is known to degrade the enzyme (Daly and Hearn,
2005). Therefore, colony 6 was selected for recombinant
enzyme production. Casamino acid (1%) and sorbitol
(3%) were added to the media for protease inhibition
and increasing of the cell growth, respectively. According
to western blot analysis (Figure 3b), protein bands that
were specific to anti-6xHis-tag antibodies were observed
in every well. Western blot assay showing 6xHis-fused
hPON1 was successfully performed and it confirmed that
the protein secreted into the culture medium by P. pastoris
was rhPON1. On the other hand, protease inhibition was
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Table. Summary of different kinetic results for paraoxon hydrolysis of hPON1 from different sources.
Source

Buffer

Temperature (°C)

KM (mM)

Reference

Serum

50 mM Tris-HCl, pH 7.45

25

0.5

Gan et al. (1991)

Serum

100 mM Tris-HCl, pH 8

25

1.38

Li et al. (2000)

Serum

100 mM Tris-HCl, pH 8.5

37

0.81

Rodrigo et al. (2001)

Recombinant human PON1 in E. coli-G2E6

50 mM Tris-HCl, pH 8

Not reported

0.8

Khersonsky and Tawfik (2005)

Recombinant human PON1Q from silkworm

50 mM Tris-HCl, pH 8

37

0.6

Lu et al. (2006)

Recombinant human PON1 in P. pastoris

100 mM glycine-NaOH, pH 10

15

0.025

This study

observed with increased enzyme activity every 24 h, up
to hour 96. However, as seen from Figure 4a, decreased
enzyme activity after 96 h of incubation may be attributed
to excessive protease secretion caused by increased
biomass. As mentioned above, the probable reason for
the low activity value of hPON1 might be the existence of
proteases in the culture medium.
It is well known that the hPON1 sequence has four
potential N-glycosylation sites. Two of them (Asn 227
and Asn 270) are in the center of a beta-pleated sheet,
while the others (Asn 253 and Asn 324) are in the zone
of the interior (Draganov and La Du, 2004). The present
results of SDS-PAGE and western blot suggested that
the molecular mass of the rhPON1 was slightly larger
than the molecular mass of hPON1, which is 43‒45 kDa
glycoprotein. Similarly, Li et al. (2011) reported that
human interleukin-3 from P. pastoris showed molecular
mass of 19‒22 kDa in comparison with the calculated
molecular mass (15‒17 kDa) and explained this result as
different degrees of N-linked glycosylation. Based on these
results, we thought that this enhancement was derived
from the glycosylation of the target protein, which is an
extensive posttranslational modification in P. pastoris.
After determination of activity and molecular
mass of the recombinant enzyme, enzyme purification
was performed and the eluted enzyme was used for

characterization studies. According to the results, KM value
was determined as 0.025 mM in 100 mM glycine-NaOH
buffer (pH 10) containing 2 mM Ca2+ at 15 °C. In the
literature, different KM values were reported for paraoxon
substrate, as shown in the Table. These differences in KM
(affinity) values can derive from purity grade of enzyme
extract and substrate, buffer pH, environment temperature,
and substrate concentration.
The results of the present study show that P. pastoris is
a suitable system for the effective expression of hPON1.
The purified paraoxonase activity was 18.9 U/mL and
the activity could reach 31.27 U/mL by means of the
characterization studies. In conclusion, production of
hPON1 at an industrial scale may be improved by using cell
immobilization technology and performing optimization
of the culture conditions. Besides, the purified enzyme may
be tested in cell culture in order to elucidate its antioxidant
potential and used for another functional and structural
study as well as possible clinical therapy. However, further
studies are required to prove these assumptions.
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